“CONCLUSION Ch omium picolinate si gnificantly decreased TG, ins ulin, H OMA-IR, fetuin-A, the number of inflammatory factors, and increased QUICKI without changing FBS, HbA1C, TC, LDL, HDL, IL-17 levels and liver steatosis intensity in patients with NAFLD.”